Semaglutide medications work by activating the GLP-1 receptor alone, while tirzepatide medications activate both the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor, creating what is commonly described as a dual incretin mechanism
Can I use the calculator if Im not on a GLP-1
So, we asked for even more responses and once again, people delivered
Importantly, individuals with T2DM continue to benefit from GLP- 1's glucose-lowering effects
A 2021 study found that individuals on a higher dose of GLP-1 lost an average of 15% (34 lbs) weight loss, with 44% of that weight loss (15 lbs) coming from muscle (Wilding et al, 2021)
Having this information ready makes the consultation more efficient and helps your provider make the best clinical decision for your care